About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 388 record(s)
Req # A-2023-000015
All acknowledgment letters issued by Health Canada confirming receipt of Abbreviated New Drug Submissions (ANDS) for a drug containing Ivacaftor as medicinal ingredient. The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug containing Ivacaftor as medicinal ingredient. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for the generic drug containing Ivacaftor as medicinal ingredient. The strength (s) and dosage form of any and all generic drugs containing Ivacaftor as medicinal ingredient.Organization: Health Canada
April 2023
Req # A-2023-000029
All records conducted by Health Canada between January 2019 and March 2023 regarding the usage of Messenger Ribonucleic Acid (mRNA) vaccines in livestock.Organization: Health Canada
April 2023
Req # A-2021-001192
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-112624-851.Organization: Health Canada
April 2023
Req # A-2022-000318
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102891-541.Organization: Health Canada
April 2023
Req # A-2022-000474
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-104961-175.Organization: Health Canada
April 2023
Req # A-2022-000892
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107163-610.Organization: Health Canada
April 2023
Req # A-2022-001049
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110429-136.Organization: Health Canada
April 2023
Req # A-2022-001053
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075679-403, Deputy Ministerial Meeting with Intact Centre on Climate Adaptation.Organization: Health Canada
April 2023
Req # A-2022-001105
Adverse Drug Reactions (ADRs). Report numbers: E2B_05637790, E2B_05712287, E2B_05625151, E2B_05643257, E2B_05702165, E2B_05651561, E2B_05637440, E2B_05645963, E2B_05612910, E2B_05658511.Organization: Health Canada
April 2023
Req # A-2022-001163
Adverse Drug Reactions (ADRs). Report numbers: 000997791, E2B_05432236, E2B_05432077, E2B_05418969, E2B_05485269, E2B_05474361, E2B_05473315, E2B_05441510, E2B_05475299, 001000066.Organization: Health Canada
April 2023